Codexis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. 

CEO
Stephen George Dilly
CEOStephen George Dilly
Employees
188
Employees188
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2002
Founded2002
Employees
188
Employees188

CDXS Key Statistics

Market cap
228.65M
Market cap228.65M
Price-Earnings ratio
-2.80
Price-Earnings ratio-2.80
Dividend yield
Dividend yield
Average volume
1.14M
Average volume1.14M
High today
$2.91
High today$2.91
Low today
$2.69
Low today$2.69
Open price
$2.84
Open price$2.84
Volume
1.47M
Volume1.47M
52 Week high
$6.08
52 Week high$6.08
52 Week low
$1.90
52 Week low$1.90

CDXS News

Simply Wall St 16h
What You Can Learn From Codexis, Inc.'s P/S

When you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3x, Codexis, Inc....

What You Can Learn From Codexis, Inc.'s P/S
TipRanks 2d
Major Shareholder Makes Bold Move with Codexis Stock Purchase

New insider activity at Codexis ( (CDXS) ) has taken place on July 1, 2025. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off!...

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.